An article Chemical proteomics reveals target selectivity of clinical Jak inhibitors in human primary cells WOS:000488481500022 published article about CYCLIN-DEPENDENT KINASE; DRUG TARGET; OFF-TARGET; KINOME; MUTATION; IDENTIFICATION; TOFACITINIB; RUXOLITINIB; DISCOVERY; PLACEBO in [Eberl, H. Christian; Werner, Thilo; Reinhard, Friedrich B.; Lehmann, Stephanie; Thomson, Douglas; Rau, Christina; Muelbaier, Marcel; Drewes, Gerard; Bantscheff, Marcus] Cellzome GmbH, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Chen, Peiling; Zhang, Cunyu] GlaxoSmithKline, 709 Swedeland Rd 1539, King Of Prussia, PA 19406 USA; [Drewry, David] GlaxoSmithKline, 5 Moore Dr, Res Triangle Pk, NC 27709 USA; [Drewry, David] Univ North Carolina Chapel Hill, UNC Eshelman Sch Pharm, Struct Genom Consortium, 120 Mason Farm Rd, Chapel Hill, NC 27599 USA in 2019, Cited 60. Category: thiomorpholine. The Name is 2-Aminobenzamide. Through research, I have a further understanding and discovery of 88-68-6
Kinobeads are a set of promiscuous kinase inhibitors immobilized on sepharose beads for the comprehensive enrichment of endogenously expressed protein kinases from cell lines and tissues. These beads enable chemoproteomics profiling of kinase inhibitors of interest in dose-dependent competition studies in combination with quantitative mass spectrometry. We present improved bead matrices that capture more than 350 protein kinases and 15 lipid kinases from human cell lysates, respectively. A multiplexing strategy is suggested that enables determination of apparent dissociation constants in a single mass spectrometry experiment. Miniaturization of the procedure enabled determining the target selectivity of the clinical BCR-ABL inhibitor dasatinib in peripheral blood mononuclear cell (PBMC) lysates from individual donors. Profiling of a set of Jak kinase inhibitors revealed kinase off-targets from nearly all kinase families underpinning the need to profile kinase inhibitors against the kinome. Potently bound off-targets of clinical inhibitors suggest polypharmacology, e.g. through MRCK alpha and beta, which bind to decernotinib with nanomolar affinity.
Category: thiomorpholine. Welcome to talk about 88-68-6, If you have any questions, you can contact Eberl, HC; Werner, T; Reinhard, FB; Lehmann, S; Thomson, D; Chen, PL; Zhang, CY; Rau, C; Muelbaier, M; Drewes, G; Drewry, D; Bantscheff, M or send Email.
Reference:
Thiomorpholine – Wikipedia,
,Thiomorpholine | C4H9NS – PubChem